Raise by Fusion42
Fusion42 Scout Wire
Capital Reports
Who's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC
Benchmarks
Benchmarks HomeFundsRoundsSectors
AI VC IndexCapital FlowAbout

Switch product

Fusion42RaiseScoutWire

Capital Reports

All editionsWho's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC

Database & benchmarks

Benchmarks HomeFundsRoundsSectorsStagesAI VC IndexCapital Flow Index

Account

Sign in
← Back

Sofinnova Partners | Sofinnova MD Start IV

vc$82M

◆ Fund Size

$82M

◆ Location

France

◆ Activity

Statusraising

◆ Links

Website ↗@sofinnovaparis on X ↗

◆ Share this fund

ShareXLinkedInEmail

◆ Investment Thesis

European life sciences venture capital with a medtech company-creation strategy focused on launching and supporting early-stage medtech companies from inception through key clinical and operational milestones; the newly announced Sofinnova MD Start IV is expected to expand this strategy across Europe and the US and to launch six to eight new medtech companies over the next five years.

◆ About Sofinnova Partners

A €82 million medtech-focused venture fund dedicated to creating and supporting new medtech companies from inception through clinical and operational milestones across Europe and the US. The fund plans to launch six to eight new medtech companies over the next five years.

◆ Sectors

Medtech

◆ Stages

pre-seedseedseries-aseries-b

◆ Geography Focus

EuropeUnited States

◆ FAQ

What does Sofinnova MD Start IV invest in?

Sofinnova MD Start IV invests in Medtech at the pre-seed, seed, series-a and series-b stages.

Which geographies does Sofinnova MD Start IV focus on?

Sofinnova MD Start IV focuses on Europe and United States, and is headquartered in France.